Le-Thai, C. Guiddir, T. Stern, R. Smilov, M. Pigeot, J.-C. Merzouk, A. Billard-Larue, C. de Menibus, A.-C. Nemni, A.
Published in
Revue Francaise D'Allergologie (2009)
But de l’étude Plusieurs études ont confirmé l’impact du confinement sur la population, entraînant une rupture de soins, des effets somatiques et psychologiques. Notre étude s’intéresse aux effets indésirables et aux problèmes d’observance au cours d’immunothérapie orale (ITO) alimentaires pendant le confinement. Patients et méthodes Au total, 132 ...
Wongteerayanee, Chulamanee Tanticharoenwiwat, Pattara Rutrakool, Nuntanut Senavonge, Anchalee Jeekungwal, Nivat Pacharn, Punchama Vichyanond, Pakit
Published in
Asia Pacific Allergy
Background Wheat allergy is not an uncommon event among Thai children. Despite strict avoidance, some patients developed reactions after accidental exposure to minute amount of wheat and thus disturbed their quality of life. Wheat oral immunotherapy (OIT) has been reported to be an alternative treatment for such patients. Objective We designed a ne...
Hise, Kathleen Rabin, Ronald L.
Published in
Current Allergy and Asthma Reports
The recent approval of Palforzia for treatment of peanut allergy by the US Food and Drug Administration (USFDA) predicts that additional products for oral immunotherapy (OIT) are on the horizon. In this article, the authors review the legal framework by which the USFDA regulates products for OIT of food allergy and the clinical data that demonstrat...
Marcucci, Francesco Isidori, Chiara Argentiero, Alberto Neglia, Cosimo Esposito, Susanna
Published in
Journal of Translational Medicine
BackgroundIn the last twenty years, several studies have been conducted in the search for new therapeutic strategies in patients with food allergy; in particular, after the failure of injection immunotherapy, three different routes of administration, oral immunotherapy (OIT), sublingual immunotherapy (SLIT), and epicutaneous immunotherapy (EPIT), h...
Tomar, Sunil Hogan, Simon P
Published in
F1000Research
Food allergens are innocuous proteins that promote tolerogenic adaptive immune responses in healthy individuals yet in other individuals induce an allergic adaptive immune response characterized by the presence of antigen-specific immunoglobulin E and type-2 immune cells. The cellular and molecular processes that determine a tolerogenic versus non-...
Ebisawa, Motohiro Ito, Komei Fujisawa, Takao
Published in
Allergology international : official journal of the Japanese Society of Allergology
Five years have passed since the Japanese Pediatric Guideline for Food Allergy (JPGFA) was first revised in 2011 from its original version. As many scientific papers related to food allergy have been published during the last 5 years, the second major revision of the JPGFA was carried out in 2016. In this guideline, food allergies are generally cla...
Takaoka, Yuri Yajima, Yuko Ito, Yoichi M. Kumon, Junko Muroya, Takahiro Tsurinaga, Yuki Shigekawa, Amane Takahashi, Shinichi Iba, Norihito Tsuji, Taisuke
...
Published in
International Archives of Allergy and Immunology
Introduction: Oral immunotherapy (OIT) has been reported to be effective but associated with a risk of severe symptoms. Thus, an OIT method with decreased risk is required. Objectives: We aimed to evaluate the efficacy and safety of low- and high-dose OIT regimens in children with severe milk allergy. Methods: Overall, 33 participants (median age, ...
Protudjer, Jennifer Lisa Penner Soller, Lianne Abrams, Elissa Michelle Chan, Edmond S.
Published in
Allergy, Asthma & Clinical Immunology
BackgroundThe prevalence of food allergy in Canada is high and has increased over time. To date, there are no Canadian data on the healthcare costs of visits to allergists.MethodsWe sent an anonymous survey to allergist members of the Canadian Society of Allergy and Clinical Immunology (CSACI) between October and December 2019. Survey questions inc...
Patrawala, Meera Shih, Jennifer Lee, Gerald Vickery, Brian
Published in
Current Allergy and Asthma Reports
Purpose of the ReviewPeanut oral immunotherapy (OIT) is one of the most studied experimental therapies for food allergy. With the recently FDA-approved peanut product, Palforzia, the goal of this article is to review the most recent data from clinical trials, discuss recent trends, and anticipate future developments.Recent FindingsThe latest resear...
Langlois, Alexandra Lavergne, Marie-Hélène Leroux, Hélène Killer, Kerstin Azzano, Pauline Paradis, Louis Samaan, Kathryn Lacombe-Barrios, Jonathan Mâsse, Benoît Des Roches, Anne
...
Published in
Allergy, Asthma & Clinical Immunology
BackgroundPrevious proof-of-concept studies have shown that a short course of omalizumab can safely accelerate the oral immunotherapy schedule for multiple allergens simultaneously. Considering the high cost of medication, the dose-related efficacy of omalizumab at decreasing the duration of oral immunotherapy up-dosing phase must be objectively qu...
